HAVING SERVED on college of pharmacy admission committees for a number of years, I am impressed by the general lack of state, regional, or national guidance to colleges in terms of present and future manpower needs. Each college procreates at will. The humble faculty on the admissions committee will muster comments on the need to admit only competent students while the dean will speak of the exigencies of maintaining enrollment. As long as graduates are getting jobs, no matter the simplicity of the professional challenge, everything is fine. A few advertisements of immediate openings for aggressive pharmacists in some new shopping centers bless the entire admissions process. Is there a rational way to plan for professional manpower?
The most recent thoughtful look at U.S. pharmacy manpower was in the mid-1960s. Hager noted that since World War II, about 3600 new graduates were produced each year; about 4300 pharmacists were being lost each year at the time of his report. Considering the expanding population, pending health care legislation, and new therapeutic developments, a projected need of 7200 graduates annually by 1970 was forecast. Hager noted the underutilization of pharmacists, but acknowledged there was no simple formula to factor for this problem. 1 The profession generally was not ready for advanced use of technical personnel at this time. While some such as Hager pointed out the advantages of support persons, others cast up the spector of the horrors of assistants out of control. Harvey Whitney, Jr., and the late Donald E. Francke have made over the past 15 years the most consistent case for training of advanced supportive personnel.
With the enticement of federal capitation support for pharmacy students, pharmacy schools greatly increased the number of graduates during the 1970sso that a ratio of about 1:1500 has been maintained for pharmacists to the population. This figure maintains the status quo for pharmacy manpower before the introduction of clinical pharmacy and at a time when most pharmacists anticipated mainly dispensing functions in their career.
What has been medicine's experience during this same period (1965-85)? Medical school enrollments were increased, many new medical schools were created, and foreign-trained physicians continued a large exodus to America. Shortages of physicians in many rural communities provided much of the political and emotional impetus for these increases in physicians. American medicine is now predicting a physician glut, rising costs, and the existence of many poorly trained and marginally employed physicians. Retrenchment in medical schools is difficult; the new schools have strong political support and cavernous appetites for tuition income. A few in medicine said all along that the problem was not a lack of physicians, but one of too many narrowlytrained specialists, who were clustered in large cities.
How many pharmacists are needed? Is there something more clever than simply slapping a drug store in every new shopping center and creating a legal need for more pharmacists? Data from selected northern European countries may be instructive. These countries were chosen for the following reasons: (1) reliable pharmaceutical and health manpower data are available, (2) they are industrialized, western nations with similar societal expectations to that of the U.S., (3) the logic and quality of overall medical care is similar to the U.S., and (4) there is central planning for pharmacy as a profession and public health resource.
Macroscopic medical and pharmaceutical manpower data are shown in Table I for Denmark," Finland," The Netherlands (personal communication, E. van der Kleijn, Nijmegen, The Netherlands, March 1985), Sweden," and the U.S. 5.6 Inspection of these data shows that the annual number of prescriptions per capita is not grossly different between the four countries (range 4.5-6.5). The population per pharmacist, however, varies tremendously, from a low of 1500 in the U.S. to 11857 in Sweden. Likewise, the population per pharmacy ranges greatly, from a low of 5010 in the U.S. to a high of 16318 in Denmark. Annual prescription productivity per pharmacist varies more than five-fold, from a low of 9760 in the U.S. to 54800 in Sweden. Another interesting facet to these data is the ratio of physicians to pharmacists. There are about three physicians per pharmacist in the U.S., but more than 30 per pharmacist in Sweden.
There are many differences in pharmacy practice among these countries, but a few clear dichotomies exist. By regulation, pharmacies are engaged strictly in health care activities in Denmark, Finland, The Netherlands, and Sweden. They are also controlled in number and location of practice. Pharmaceutical manpower is not wasted on general mercantile activities as it so frequently is in the U.S. Each of these countries has a rational plan for training capable supportive personnel, referred to variously as prescriptionists, assistants, or technologists. These persons are trained generally in two-year programs, although three years are required for hospital technologists in The Netherlands, and four years currently for Finnish technologists. The numbers shown do not include technicians or clerks who are largely trained on the job. Interestingly, the number of pharmacists and technologists combined in these countries approximates the number of pharmacists per capita in the U.S.
Another key difference is the ownership of pharmacies. In Denmark, Finland, and The Netherlands there are no chain pharmacies and pharmacies are owned only and totally by pharmacists. There are employee pharmacists, but only a pharmacist can own a pharmacy. In Sweden, the pharmacies are owned and operated by a national professional corporation (Apotekbolaget), of which the government is the majority owner and the corporation the minority owner. These situations contrast sharply with pharmacies and corporate chains of pharmacies in the U.S., which can be owned by anyone and by general stockholders. Cowen has described the differences in pharmacy development in the U.S. and Britain as compared to nations with a Germanic pharmacy tradition."
What conclusions can be reached from these comparative data and from gross observations of pharmacy practice in these countries? The Europeans have applied production management techniques to pharmacy practice far more thoroughly than have Americans. It seems somewhat of an anomaly at the close of the 20th century to have five-to six-year university programs for American-trained pharmacists who will spend the majority of their time performing activities now done by two-year assistants in other countries.
The extensiveuse of technologists has not undermined the essential role of pharmacists in northern Europe nor has it taken control of the profession away from pharmacists. Sweden perhaps is somewhat of an exception. The Swedish government owns two-thirds of the controlling national corporation and some remote pharmacies are being operated day-to-day by technologists, who report to central pharmacists. Swedish pharmacists, however, are highly organized to meet the medication supply needs of society. A further element in these countries is that nonprescription drugs are almost totally supplied through pharmacies. Contrast this to the widespread availability of these drugs in supermarkets, gasoline stations, and convenience stores in the U.S. In fact, it is probably easier to compare most U.S. drug stores to supermarkets than to professional northern European pharmacies.
Clinical pharmacy, represented by physician consultation and participation in direct therapeutic management of patients, is an uncommon feature of community pharmacy in northern Europe and the U.S. It will be interesting to see if clinical pharmacy can be more easily added to a planned drug distribution system as in northern Europe or to a more mercantile and uncontrolled system as exists in the U.S. Pharmacy manpower planning in northern Europe is more successful than in the U.S. because of historical traditions as well as political and economic structures. American pharmacy increased student output in the 1970s with federal government support and encouragement. That support is now ended. Cannot pharmacy decrease considerably the number of graduates, improve the quality of admitted students, and slowly allow the development of a profession very busy with only drugs and health care? The conglomerate pharmacy chains are already offering to aid in student recruitment so that professional labor remains cheap and an even greater number of emporiums, masquerading as pharmacies, dot every village and shopping center. Cannot a wise plan for pharmacy and the public health occur within a free enterprise nation? Could not this idea be the focus
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for unified strategic planning among those pharmacy associations that can still rally behind the semblance of professionalism?
